Toward improved in vitro models of human cancer
Cancer is a leading cause of death across the world and continues to increase in incidence. Despite years of research, multiple tumors (e.g., glioblastoma, pancreatic cancer) still have limited treatment options in the clinic. Additionally, the attrition rate and cost of drug development have contin...
Main Authors: | Jose M. Ayuso, Keon-Young Park, María Virumbrales-Muñoz, David J. Beebe |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2021-03-01
|
Series: | APL Bioengineering |
Online Access: | http://dx.doi.org/10.1063/5.0026857 |
Similar Items
-
Breast Fibroblasts and ECM Components Modulate Breast Cancer Cell Migration Through the Secretion of MMPs in a 3D Microfluidic Co-Culture Model
by: Karina M. Lugo-Cintrón, et al.
Published: (2020-05-01) -
Microfluidic Tumor-on-a-Chip Model to Study Tumor Metabolic Vulnerability
by: Jose M Ayuso, et al.
Published: (2020-11-01) -
Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinomaResearch in context
by: José A. Jiménez-Torres, et al.
Published: (2019-04-01) -
Toward improved models of human cancer
by: Bryan E. Welm, et al.
Published: (2021-03-01) -
Toward improved models of human cancer: Two perspectives
by: Roger D. Kamm
Published: (2021-03-01)